(Q34545360)

2 August 2017

1 reference

title

Quetiapine. A review of its use in the management of schizophrenia (English)

1 reference

2 August 2017

0 references

2

Antona J Wagstaff

1 reference

2 August 2017

Susan M Cheer

1

1 reference

2 August 2017

1 January 2004

1 reference

2 August 2017

1 reference

2 August 2017

18

1 reference

2 August 2017

173-199

1 reference

2 August 2017

3

1 reference

https://scigraph.springernature.com/pub.10.2165/00023210-200418030-00004

2 August 2017

0 references

cites work

Fatalities associated with therapeutic use and overdose of atypical antipsychotics

1 reference

12 December 2020

Relationship of atypical antipsychotics with development of diabetes mellitus

1 reference

12 December 2020

Contrasting effects of chronic clozapine, Seroquel(TM) (ICI 204,636) and haloperidol administration of deltaFosB-like immunoreactivity in the rodent forebrain

1 reference

12 December 2020

The long-term effect of quetiapine (Seroquel TM ) monotherapy on weight in patients with schizophrenia.

1 reference

12 December 2020

The new and evolving pharmacotherapy of schizophrenia

1 reference

12 December 2020

Efficacy of quetiapine and risperidone against depressive symptoms in outpatients with psychosis

1 reference

12 December 2020

The safety and pharmacokinetics of quetiapine when coadministered with haloperidol, risperidone, or thioridazine

1 reference

12 December 2020

The effects of concomitant phenytoin administration on the steady-state pharmacokinetics of quetiapine

1 reference

12 December 2020

Efficacy of newer generation antipsychotics in the treatment of schizophrenia

1 reference

12 December 2020

Advances in atypical antipsychotics for the treatment of schizophrenia: new formulations and new agents

1 reference

12 December 2020

A comparison of quetiapine and chlorpromazine in the treatment of schizophrenia

1 reference

12 December 2020

Conventional antipsychotic medications for schizophrenia

1 reference

12 December 2020

Seroquel: behavioral effects in conventional and novel tests for atypical antipsychotic drug.

1 reference

12 December 2020

Improvement in cognitive functioning in patients with first-episode psychosis during treatment with quetiapine: an interim analysis

1 reference

12 December 2020

Quetiapine and cataracts

1 reference

12 December 2020

Quetiapine ('Seroquel'); an effective and well-tolerated atypical antipsychotic

1 reference

12 December 2020

Pharmacokinetics, tolerability, and clinical effectiveness of quetiapine fumarate: an open-label trial in adolescents with psychotic disorders

1 reference

12 December 2020

Open-label study of the effect of combination quetiapine/lithium therapy on lithium pharmacokinetics and tolerability

1 reference

12 December 2020

Elevated prolactin levels in patients with schizophrenia: mechanisms and related adverse effects

1 reference

12 December 2020

The efficacy of atypical antipsychotics in the treatment of depressive symptoms, hostility, and suicidality in patients with schizophrenia

1 reference

12 December 2020

A review of the effect of atypical antipsychotics on weight

1 reference

12 December 2020

Does cognitive function improve with quetiapine in comparison to haloperidol?

1 reference

12 December 2020

Efficacy and tolerability of quetiapine in patients with schizophrenia switched from other antipsychotics.

1 reference

12 December 2020

A comparison of the effects of quetiapine ('seroquel') and haloperidol in schizophrenic patients with a history of and a demonstrated, partial response to conventional antipsychotic treatment. PRIZE Study Group

1 reference

12 December 2020

Clinical pharmacokinetics of quetiapine: an atypical antipsychotic

1 reference

12 December 2020

Quetiapine in patients with schizophrenia. A high- and low-dose double-blind comparison with placebo. Seroquel Study Group

1 reference

12 December 2020

Refractory schizophrenia and atypical antipsychotics

1 reference

12 December 2020

A comparison of the relative safety, efficacy, and tolerability of quetiapine and risperidone in outpatients with schizophrenia and other psychotic disorders: the quetiapine experience with safety and tolerability (QUEST) study

1 reference

12 December 2020

Quetiapine: a well-tolerated and effective atypical antipsychotic

1 reference

12 December 2020

Quetiapine : A Review of its Use in Schizophrenia

1 reference

12 December 2020

Patients' subjective experiences of antipsychotics: clinical relevance

1 reference

12 December 2020

Frequency of sexual dysfunction and other reproductive side-effects in patients with schizophrenia treated with risperidone, olanzapine, quetiapine, or haloperidol: the results of the EIRE study

1 reference

12 December 2020

A post hoc analysis of the impact on hostility and agitation of quetiapine and haloperidol among patients with schizophrenia

1 reference

12 December 2020

Long-term safety, tolerability, and clinical efficacy of quetiapine in adolescents: an open-label extension trial

1 reference

12 December 2020

Patient satisfaction and acceptability of long-term treatment with quetiapine

1 reference

12 December 2020

Cognitive effects and antipsychotic treatment.

1 reference

12 December 2020

Atypical antipsychotics in the treatment of schizophrenia

1 reference

12 December 2020

Olanzapine. A pharmacoeconomic review of its use in schizophrenia

1 reference

12 December 2020

Practice guideline for the treatment of patients with schizophrenia. American Psychiatric Association

1 reference

12 December 2020

Attentional improvement following quetiapine fumarate treatment in schizophrenia.

1 reference

12 December 2020

Induction patterns of Fos-like immunoreactivity in the forebrain as predictors of atypical antipsychotic activity

1 reference

12 December 2020

Effect of fluoxetine and imipramine on the pharmacokinetics and tolerability of the antipsychotic quetiapine

1 reference

12 December 2020

A positron emission tomography study of quetiapine in schizophrenia: a preliminary finding of an antipsychotic effect with only transiently high dopamine D2 receptor occupancy

1 reference

12 December 2020

Quetiapine, an atypical antipsychotic

1 reference

12 December 2020

Antipsychotics and QT prolongation

1 reference

12 December 2020

Antipsychotic-induced type 2 diabetes: evidence from a large health plan database

1 reference

12 December 2020

Single-dose pharmacokinetics of quetiapine in subjects with renal or hepatic impairment

1 reference

12 December 2020

Drug treatments for schizophrenia

1 reference

12 December 2020

Relapse and rehospitalisation rates in patients with schizophrenia: effects of second generation antipsychotics

1 reference

12 December 2020

An economic assessment of quetiapine and haloperidol in patients with schizophrenia only partially responsive to conventional antipsychotics

1 reference

12 December 2020

Atypical antipsychotic effects of quetiapine fumarate in animal models

1 reference

12 December 2020

Prolactin and schizophrenia: clinical consequences of hyperprolactinaemia

1 reference

12 December 2020

A study of quetiapine: efficacy and tolerability in psychotic adolescents

1 reference

12 December 2020

Multiple fixed doses of "Seroquel" (quetiapine) in patients with acute exacerbation of schizophrenia: a comparison with haloperidol and placebo. The Seroquel Trial 13 Study Group

1 reference

12 December 2020

ICI 204,636, an atypical antipsychotic: efficacy and safety in a multicenter, placebo-controlled trial in patients with schizophrenia. U.S. SEROQUEL Study Group

1 reference

12 December 2020

Weight gain in patients with schizophrenia treated with risperidone, olanzapine, quetiapine or haloperidol: results of the EIRE study

1 reference

12 December 2020

Review of quetiapine and its clinical applications in schizophrenia

1 reference

12 December 2020

Activity of “Seroquel” (ICI 204,636) in Animal Models for Atypical Properties of Antipsychotics: A Comparison with Clozapine

1 reference

12 December 2020

Differential effect of quetiapine on depressive symptoms in patients with partially responsive schizophrenia

1 reference

12 December 2020

Receptor and transporter imaging studies in schizophrenia, depression, bulimia and Tourette's disorder--implications for psychopharmacology

1 reference

12 December 2020

Time course of central nervous dopamine-D2 and 5-HT2 receptor blockade and plasma drug concentrations after discontinuation of quetiapine (Seroquel) in patients with schizophrenia

1 reference

12 December 2020

Seroquel: electrophysiological profile of a potential atypical antipsychotic.

1 reference

12 December 2020

A multicentre, double-blind, randomized comparison of quetiapine (ICI 204,636, 'Seroquel') and haloperidol in schizophrenia

1 reference

12 December 2020

Atypical antipsychotics: Part II: Adverse effects, drug interactions, and costs

1 reference

12 December 2020

Seroquel: biochemical profile of a potential atypical antipsychotic.

1 reference

12 December 2020

The effectiveness of quetiapine versus conventional antipsychotics in improving cognitive and functional outcomes in standard treatment settings

1 reference

12 December 2020

Quetiapine: preclinical studies, pharmacokinetics, drug interactions, and dosing.

1 reference

12 December 2020

Long-Term use of quetiapine in elderly patients with psychotic disorders

1 reference

12 December 2020

Depression in first-episode schizophrenia

1 reference

12 December 2020

The efficacy of quetiapine vs haloperidol and placebo: a meta-analytic study of efficacy

1 reference

12 December 2020

The effects of atypical antipsychotics on serum prolactin levels

1 reference

12 December 2020

Quetiapine fumarate (Seroquel): a new atypical antipsychotic.

1 reference

12 December 2020

Neuropsychological change in patients with schizophrenia after treatment with quetiapine or haloperidol

1 reference

12 December 2020

10.2165/00023210-200418030-00004

Identifiers

DOI

1 reference

PubMed ID

14871161

Dimensions Publication ID

2 August 2017

0 references

1 reference

PubMed ID

14871161